全文获取类型
收费全文 | 14339篇 |
免费 | 1422篇 |
国内免费 | 3493篇 |
专业分类
19254篇 |
出版年
2024年 | 88篇 |
2023年 | 286篇 |
2022年 | 619篇 |
2021年 | 820篇 |
2020年 | 659篇 |
2019年 | 727篇 |
2018年 | 649篇 |
2017年 | 529篇 |
2016年 | 667篇 |
2015年 | 1024篇 |
2014年 | 1136篇 |
2013年 | 1195篇 |
2012年 | 1483篇 |
2011年 | 1336篇 |
2010年 | 816篇 |
2009年 | 859篇 |
2008年 | 882篇 |
2007年 | 813篇 |
2006年 | 766篇 |
2005年 | 661篇 |
2004年 | 546篇 |
2003年 | 417篇 |
2002年 | 387篇 |
2001年 | 304篇 |
2000年 | 290篇 |
1999年 | 223篇 |
1998年 | 142篇 |
1997年 | 100篇 |
1996年 | 90篇 |
1995年 | 88篇 |
1994年 | 71篇 |
1993年 | 49篇 |
1992年 | 78篇 |
1991年 | 60篇 |
1990年 | 56篇 |
1989年 | 40篇 |
1988年 | 39篇 |
1987年 | 33篇 |
1986年 | 28篇 |
1985年 | 35篇 |
1984年 | 24篇 |
1983年 | 16篇 |
1982年 | 18篇 |
1981年 | 10篇 |
1978年 | 8篇 |
1975年 | 5篇 |
1973年 | 5篇 |
1971年 | 6篇 |
1970年 | 6篇 |
1957年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 9 毫秒
241.
目的:观察唑来膦酸联合钙尔奇D治疗糖尿病性骨质疏松症的临床疗效。方法:将120例糖尿病性骨质疏松患者随机分为实验组和对照组,实验组60例予唑来膦酸联合钙尔奇D治疗,对照组60例予钙尔奇D治疗。连续治疗12个月后,比较两组患者的骨密度、疼痛评分及不良反应的发生情况。结果:治疗12个月后,实验组患者的股骨颈、股骨粗隆和腰椎正位的骨密度均较对照组明显升高,差异有统计学意义(P0.05);VAS疼痛评分较对照组显著降低(P0.05)。治疗过程中,两组均无严重的不良反应发生。结论:唑来膦酸联合钙尔奇D治疗糖尿病性骨质疏松临床效果优于钙尔奇D单药治疗。 相似文献
242.
Zongyou Yang Wei Chen Zhidao Xia Yueju Liu Shaun Peggrem Tao Geng Zhaoxu Yang Han Li Bin Xu Chi Zhang James T. Triffitt Yingze Zhang 《PloS one》2015,10(5)
Delayed healing or non-union of skeletal fractures are common clinical complications. Ibandronate is a highly potent anti-catabolic reagent used for treatment of osteopenia and fracture prevention. We hypothesized that local application of ibandronate after fracture fixation may improve and sustain callus formation and therefore prevent delayed healing or non-union. This study tested the effect of local application of an ibandronate/gelatin sponge composite on osteotomy healing. A right-side distal-femoral osteotomy was created surgically, with fixation using a k-wire, in forty adult male rabbits. The animals were divided into four groups of ten animals and treated by: (i) intravenous injection of normal saline (Control); (ii) local implantation of absorbable gelatin sponge (GS); (iii) local implantation of absorbable GS containing ibandronate (IB+GS), and (iv) intravenous injection of ibandronate (IB i.v.). At two and four weeks the affected femora were harvested for X-ray photography, computed tomography (CT), biomechanical testing and histopathology. At both time-points the results showed that the calluses in both the ibandronate-treated groups, but especially in the IB+GS group, were significantly larger than in the control and GS groups. At four weeks the cross sectional area (CSA) and mechanical test results of ultimate load and energy in the IB+GS group were significantly higher than in other groups. Histological procedures showed a significant reduction in osteoclast numbers in the IB+GS and IB i.v. groups at day 14. The results indicate that local application of an ibandronate/gelatin sponge biomaterial improved early osteotomy healing after surgical fixation and suggest that such treatment may be a valuable local therapy to enhance fracture repair and potentially prevent delayed or non-union. 相似文献
243.
Sihua Liu Hongyun Liu Keke Zhang Xueping Li Yuqin Duan Zhiyun Wang Tao Wang 《中国病毒学》2019,34(5):572-582
Severe fever with thrombocytopenia syndrome(SFTS) is an emerging hemorrhagic fever disease caused by SFTSV, a newly discovered phlebovirus that is named after the disease. Currently, no effective vaccines or drugs are available for use against SFTSV infection, as our understanding of the viral pathogenesis is limited. Bortezomib(PS-341), a dipeptideboronic acid analog, is the first clinically approved proteasome inhibitor for use in humans. In this study, the antiviral efficacy of PS-341 against SFTSV infection was tested in human embryonic kidney HEK293 T(293 T) cells. We employed four different assays to analyze the antiviral ability of PS-341 and determined that PS-341 inhibited the proliferation of SFTSV in 293 T cells under various treatment conditions. Although PS-341 did not affect the virus absorption, PS-341 treatment within a non-toxic concentration range resulted in a significant reduction of progeny viral titers in infected cells.Dual-luciferase reporter assays and Western blot analysis revealed that PS-341 could reverse the SFTSV-encoded nonstructural protein(NS) mediated degradation of retinoic acid-inducible gene-1(RIG-I), thereby antagonizing the inhibitory effect of NSs on interferons and blocking virus replication. In addition, we observed that inhibition of apoptosis promotes virus replication. These results indicate that targeting of cellular interferon pathways and apoptosis during acute infection might serve as the bases of future therapeutics for the treatment of SFTSV infections. 相似文献
244.
245.
Shilong Piao Zhuo Liu Yilong Wang Philippe Ciais Yitong Yao Shushi Peng Frédéric Chevallier Pierre Friedlingstein Ivan A. Janssens Josep Peñuelas Stephen Sitch Tao Wang 《Global Change Biology》2018,24(2):608-616
No consensus has yet been reached on the major factors driving the observed increase in the seasonal amplitude of atmospheric CO2 in the northern latitudes. In this study, we used atmospheric CO2 records from 26 northern hemisphere stations with a temporal coverage longer than 15 years, and an atmospheric transport model prescribed with net biome productivity (NBP) from an ensemble of nine terrestrial ecosystem models, to attribute change in the seasonal amplitude of atmospheric CO2. We found significant (p < .05) increases in seasonal peak‐to‐trough CO2 amplitude (AMPP‐T) at nine stations, and in trough‐to‐peak amplitude (AMPT‐P) at eight stations over the last three decades. Most of the stations that recorded increasing amplitudes are in Arctic and boreal regions (>50°N), consistent with previous observations that the amplitude increased faster at Barrow (Arctic) than at Mauna Loa (subtropics). The multi‐model ensemble mean (MMEM) shows that the response of ecosystem carbon cycling to rising CO2 concentration (eCO2) and climate change are dominant drivers of the increase in AMPP‐T and AMPT‐P in the high latitudes. At the Barrow station, the observed increase of AMPP‐T and AMPT‐P over the last 33 years is explained by eCO2 (39% and 42%) almost equally than by climate change (32% and 35%). The increased carbon losses during the months with a net carbon release in response to eCO2 are associated with higher ecosystem respiration due to the increase in carbon storage caused by eCO2 during carbon uptake period. Air‐sea CO2 fluxes (10% for AMPP‐T and 11% for AMPT‐P) and the impacts of land‐use change (marginally significant 3% for AMPP‐T and 4% for AMPT‐P) also contributed to the CO2 measured at Barrow, highlighting the role of these factors in regulating seasonal changes in the global carbon cycle. 相似文献
246.
本研究分析肺炎肺实变患儿支气管肺泡灌洗液病原谱构成,旨在为临床经验性抗感染治疗提供指导。收集2019年1月-2020年1月复旦大学附属儿科医院纤维支气管镜室诊治的住院肺炎病例临床资料,其中肺实变的诊断基于影像学证据,依托国家儿童医学中心病原学检测平台,并参考感染传染科医生解读,本研究对肺炎伴肺实变患儿支气管肺泡灌洗液标本的病原学检测结果进行回顾性分析。结果显示,286例肺炎患儿的286份支气管肺泡灌洗液标本被纳入研究,平均年龄5.5(5.8±3.1)岁,其中195例(68.2%)存在肺炎伴肺实变。总病原体检出率为76.6%(219/286),肺实变和无肺实变肺炎患儿病原体检出率分别为77.9%(152/195)和73.6%(67/91),差异无统计学意义;检出的前5种病原体均为肺炎支原体、腺病毒、鼻病毒、呼吸道合胞病毒和副流感病毒3型。5周岁及以上患儿肺炎支原体检出率达最高77.0%(127/165),肺实变病例和无肺实变病例肺炎支原体检出率分别为67.2%(131/195)和61.5%(56/91),差异无统计学意义。本研究结果提示,肺炎支原体、腺病毒、鼻病毒、呼吸道合胞病毒和副流感病毒3型是导致本研究目标人群患病的主要病原体;病原体检出率高低与是否肺实变无关。 相似文献
247.
目的:探究我国男子橄榄球运动员的有氧能力和比赛时的能量消耗,为精准化训练和比赛时营养策略的制定提供理论依据。方法:以18名男子橄榄球运动员(健将级)为研究对象,分别进行最大摄氧量(VO2max),乳酸阈(LT)和conconi场地测试来评定其有氧能力,并比较前、后锋之间的供能差异,用wGT3X加速度计结合团队心率探究比赛时的能量消耗,所得数据进行独立样本t检验。结果:本次检测的橄榄球运动员相对最大摄氧量较差为(42.05±3.69) ml/min·kg-1,前峰队员相对最大摄氧量为(38.83±3.52) ml/min·kg-1、后锋队员相对最大摄氧量为(47.31±3.17)ml/min·kg-1,二者之间的差异有统计学意义(P<0.05);血乳酸阈测定在7 min时出现血乳酸拐点,后锋的血乳酸阈值要高于前锋运动员;conconi场地测试与实验室VO2max有较高的相关性(r=0.772)。比赛中平均能量消耗上半场约为(276.94±18.08) kcals,下半场约为(225.58±22.86) kcals,下半场的能耗小于上半场(P<0.05)。结论:英式7人制橄榄球运动员有氧能力较弱,且前、后锋队员存在差异。 相似文献
248.
Tao Zhang Guangquan Zhang Wenbo Yang Hongze Chen Jisheng Hu Zhongjie Zhao Chundong Cheng Guanqun Li Yu Xie Yilong Li Rui Kong Yongwei Wang Gang Wang Hua Chen Xue-Wei Bai Shangha Pan Bei Sun Le Li 《Cell death & disease》2021,12(11)
Chronic pancreatitis (CP) is described as progressive inflammatory fibrosis of pancreas, accompanied with irreversible impaired endocrine and exocrine insufficiency. Pancreatic stellate cells (PSCs) are widely distributed in the stroma of the pancreas and PSCs activation has been shown as one of the leading causes for pancreatic fibrosis. Our previous study has revealed that autophagy is dramatically activated in CP tissues, which facilitates PSCs activation and pancreatic fibrosis. Long non-coding RNAs (LncRNAs) have been recognized as crucial regulators for fibrosis-related diseases. LncRNAs interact with RNA binding protein or construct competitive endogenous RNA (ceRNA) hypothesis which elicited the fibrotic processes. Until now, the effects of lncRNAs on PSCs activation and pancreatic fibrosis have not been clearly explored. In this study, a novel lncRNA named Lnc-PFAR was found highly expressed in mouse and human CP tissues. Our data revealed that Lnc-PFAR facilitates PSCs activation and pancreatic fibrosis via RB1CC1-induced autophagy. Lnc-PFAR reduces miR-141 expression by suppressing pre-miR-141 maturation, which eventually upregulates the RB1CC1 and fibrosis-related indicators expression. Meanwhile, Lnc-PFAR enhanced PSCs activation and pancreatic fibrosis through trigging autophagy. Our study interrogates a novel lncRNA-induced mechanism in promoting the development of pancreatic fibrosis, and Lnc-PFAR is suggested to be a prospective therapeutic target in clinical scenarios.Subject terms: RNAi, Diagnostic markers, Chronic pancreatitis 相似文献
249.
250.
小竹鼠在我国仅分布于云南西部热带亚热带地区。主要生活于山坡稀树灌丛、阔叶林、橡胶园及居民点附近。在盈江县分布于海拔300-950米地带。取食、休息、繁殖主要在洞道内。洞系由洞口、取食道、趋避道、窝及“厕所”组成。食物主要有棕叶芦、芦竹及三叶橡胶等18种,尤喜食橡胶树主根,因而对橡胶树危害很大。13号标本中雌7雄6。在盈江每胎2-3只,以2只为多。成年小竹鼠过独居生活,雌雄各有自己的洞系。 相似文献